CI State of Play - Life Sciences 2018
This benchmarking study unveils key insights about the "state of play" of competitive intelligence in the Life Sciences industry.
The Life Sciences industry has long seen the value of competitive intelligence. With long R&D cycles involving millions (or billions) of dollars invested and a decade or longer tied up in research, keeping an eye on the competition and being first to market has always been a priority.
Our latest industry study profiles the Top 300 companies in the Life Sciences industry to understand how these companies are "doing CI" and provide guidance for professionals in every industry to improve their competitive strategy.
With this report, you will gain insight into:
“A good understanding of the science is extremely helpful for Life Sciences CI practitioners to build and maintain credibility with the key constituencies they serve within the company, especially in the research teams. Around half of my CI team have a PhD in the hard sciences.” - Martyn Smith, Head of Global Competitive Intelligence for Roche
“We sought Cipher’s expert services in our efforts to gain insight into the competitive market of wellness and health management platforms and Cipher went above and beyond our expectations to understand the nuances of our industry.“
Joe Terrion - President | New Ocean Health Solutions